| Literature DB >> 35689099 |
Lin Zhao1, Li Han2, Guozhen Hei3, Ran Wei1, Zhen Zhang1, Xiaoxiao Zhu1, Qiang Guo1, Chu Chu4, Xiaoxiao Fu4,1, Ke Xu4,1, Xia Li5,6.
Abstract
Unexplained recurrent spontaneous abortion (URSA) is commonly observed, and seriously affects women's reproductive health. Excessive interleukin-6 (IL-6) production has been shown to frequently occur and relate to URSA pathogenesis. In this study, the miRNA expression profile in peripheral blood mononuclear cells (PBMCs) from URSA patients and normal pregnant (NP) women was assessed by miRNA microarray and real-time quantitative reverse-transcription polymerase chain reaction (qPCR). MiRNA target prediction tools and luciferase reporter assay were used to detect direct binding between miRNAs and IL6. Functional study of administering anti-IL-6 neutralizing antibody and miR-374c-5p mimics to an URSA animal model was performed to evaluate embryo resorption rates. In the results, compared with NP women, the expression of IL-6 increased markedly in PBMCs and decidual tissues at both mRNA and protein levels, while miR-374c-5p expression decreased significantly. Prediction software and luciferase reporter assay showed that miR-374c-5p binds with IL6 3'UTR via the complementary bases. Transfection of miR-374c-5p mimics into an in vitro HeLa cell line significantly downregulated the expression of IL-6, while transfection of the miR-374c-5p inhibitor induced an opposite result. In the URSA mouse model, miR-374c-5p overexpression reduced the embryo resorption rate significantly, accompanied with decreased expression of IL-6 in the decidua. To sum up, downregulated miR-374c-5p was involved in the pathogenesis of URSA by enhancing IL-6 expression. Modulation of miR-374c-5p expression may be used to regulate IL-6 production for the treatment of URSA.Entities:
Keywords: IL-6; Maternal–fetal immunoregulation; Maternal–fetal immunotolerance; Non-coding RNA; Unexplained recurrent spontaneous abortion; miR-374c-5p
Mesh:
Substances:
Year: 2022 PMID: 35689099 DOI: 10.1007/s00109-022-02178-3
Source DB: PubMed Journal: J Mol Med (Berl) ISSN: 0946-2716 Impact factor: 5.606